Title : Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.

Pub. Date : 2012 Sep

PMID : 22704483






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is a lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS) and is characterized by the accumulation of glycosaminoglycans (GAGs). Glycosaminoglycans iduronate 2-sulfatase Mus musculus